EU & AstraZeneca – the supply chain dispute continues
News of progress with the roll out of the vaccine continues to make headlines, with further developments today as experts trial mixing different vaccines. But it’s also the EU’s AstraZeneca contract which has dominated today’s legal pages.
Head of Commercial Litigation at BLM, Stuart Evans, has provided his thoughts in The Times Law section today, making it clear that “interpreting what exactly [the contractual wording] means under Belgian law is likely to vex legal minds and generate vast amounts of evidence and submissions…”
Click here to read the article in full (subscription required).